Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.
Chen D; Frezza M; Schmitt S; Kanwar J; Dou QP; Current Cancer Drug Targets, 2011, vol. 11, issue 3, p 239, ISSN 18735576. ISBN 18735576.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef